Advanced Enzyme Technologies logo

ADVENZYMES - Advanced Enzyme Technologies Share Price

₹370.75 -4.5  -1.2%

Last Trade - 09/04/21

Basic Materials
Mid Cap
Market Cap £404.5m
Enterprise Value £383.0m
Revenue £46.8m
Position in Universe 451st / 3106
Unlock ADVENZYMES Revenue
Relative Strength (%)
1m +7.16%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -11.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
2,231 2,938 3,431 3,957 4,196 4,440 5,000 6,004 +14.8%
-18.9 +56.8 +15.0 -2.9 +23.0 +16.4 +17.9 +17.9
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, AdvancedEnzyme Technologies Ltd revenues increased 10% to RS3.69B.Net income increased 17% to RS1.15B. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net income benefitedfrom Other income increase of 88% to RS71.6M (income),Financecosts (includingexchange differen decrease of 50% toRS11.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ADVENZYMES
Graphical History



Net Income


Normalised EPS


PE Ratio Range


Dividend Yield Range

ADVENZYMES Dividend Yield Range Unlock ADVENZYMES Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
Profile Summary

Advanced Enzyme Technologies Limited is engaged in business of manufacturing and sale of enzymes. The Company's geographical segments include Within India and Outside India. It provides solutions to industries, such as human healthcare and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing and malting, grain processing, protein modification, dairy processing, natural extraction, textile processing, leather processing, paper and pulp processing, biofuels, biomass processing and biocatalysts. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing; non-food processing, including textiles processing, leather and bio-fuels, and oils and fats processing, including oil extraction, oil refining fish oil processing, biodiesel and oleochemicals.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated March 15, 1989
Public Since August 1, 2016
No. of Shareholders: 54,085
No. of Employees: 375
Sector Basic Materials
Industry Chemicals
Exchange National Stock Exchange of India
Shares in Issue 111,728,425
Free Float (0.0%)
Eligible for
ADVENZYMES Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ADVENZYMES
Upcoming Events for ADVENZYMES
Thursday 15th July, 2021 Estimate
Advanced Enzyme Technologies Ltd Annual Shareholders Meeting
Frequently Asked Questions for Advanced Enzyme Technologies
What is the Advanced Enzyme Technologies share price?

As of 09/04/21, shares in Advanced Enzyme Technologies are trading at ₹370.75, giving the company a market capitalisation of £404.5m. This share price information is delayed by 15 minutes.

How has the Advanced Enzyme Technologies share price performed this year?

Shares in Advanced Enzyme Technologies are currently trading at ₹370.75 and the price has moved by 0.165k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Advanced Enzyme Technologies price has moved by 61.79% over the past year.

What are the analyst and broker recommendations for Advanced Enzyme Technologies?

Of the analysts with advisory recommendations for Advanced Enzyme Technologies, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Advanced Enzyme Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Advanced Enzyme Technologies next release its financial results?

Advanced Enzyme Technologies is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Advanced Enzyme Technologies dividend yield?

The Advanced Enzyme Technologies dividend yield is 0.16% based on the trailing twelve month period.

Does Advanced Enzyme Technologies pay a dividend?

Last year, Advanced Enzyme Technologies paid a total dividend of 0.6, and it currently has a trailing dividend yield of 0.16%. Looking ahead, Advanced Enzyme Technologies has not announced an ex-dividend date yet.

When does Advanced Enzyme Technologies next pay dividends?

Advanced Enzyme Technologies has yet to annouce their ex-dividend date. The historic dividend yield on Advanced Enzyme Technologies shares is currently 0.16%.

How do I buy Advanced Enzyme Technologies shares?

To buy shares in Advanced Enzyme Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Advanced Enzyme Technologies?

Shares in Advanced Enzyme Technologies are currently trading at ₹370.75, giving the company a market capitalisation of £404.5m.

Where are Advanced Enzyme Technologies shares listed? Where are Advanced Enzyme Technologies shares listed?

Here are the trading details for Advanced Enzyme Technologies:

Country of listing: India
Exchange: NSI
Ticker Symbol: ADVENZYMES
What kind of share is Advanced Enzyme Technologies?

Based on an overall assessment of its quality, value and momentum, Advanced Enzyme Technologies is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Advanced Enzyme Technologies share price forecast 2021?

Shares in Advanced Enzyme Technologies are currently priced at ₹370.75. At that level they are trading at 5.46% discount to the analyst consensus target price of 0.00.

Analysts covering Advanced Enzyme Technologies currently have a consensus Earnings Per Share (EPS) forecast of 13.65 for the next financial year.

How can I tell whether the Advanced Enzyme Technologies share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Enzyme Technologies. Over the past six months, the relative strength of its shares against the market has been -18.13%. At the current price of ₹370.75, shares in Advanced Enzyme Technologies are trading at 26.12% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Advanced Enzyme Technologies PE Ratio?

The Advanced Enzyme Technologies PE ratio based on its reported earnings over the past 12 months is 28.42. The shares are currently trading at ₹370.75.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Advanced Enzyme Technologies?

Advanced Enzyme Technologies's management team is headed by:

Vasant Rathi - NED
Chandrakant Rathi - MDR
Mukund Kabra - EDR
Pradip Shah - NED
Kedar Desai - NEC
Beni Rauka - CFO
Piyush Rathi - CMO
Anil Gupta - VRD
Dipak Roda - VPR
Animesh Bagchi - OTH
Bhaskar Manolkar - GMG
Pradeep Bhosale - OTH
Prabal Bordiya - CCO
Rasika Rathi - NED
Sunny Sharma - NED
Who are the major shareholders of Advanced Enzyme Technologies?

Here are the top five shareholders of Advanced Enzyme Technologies based on the size of their shareholding:

Rathi (Vasant L) Individual Investor
Percentage owned: 32.74% (36.6m shares)
OrbiMed Advisors, LLC Investment Advisor/Hedge Fund
Percentage owned: 12.09% (13.5m shares)
Advanced Vital Enzymes Pvt. Ltd. Corporation
Percentage owned: 11.97% (13.4m shares)
HDFC Asset Management Co., Ltd. Investment Advisor
Percentage owned: 5.68% (6.35m shares)
HDFC Small Cap Fund Mutual Fund
Percentage owned: 4.94% (5.52m shares)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.